Follow us on FacebookFollow TorHoermanLaw on TwitterEmail Tor Hoerman Law

Corn Seed Litigation Moving Forward in Kansas

Lawsuits brought by businesses affected by declining U.S. corn market prices due in part to Chinese rejection of Syngenta's Agrisure Viptera have been consolidated under MDL No. 2591 and will be heard by Judge John W. Lungstrum in the District of Kansas. Read more

Corn Seed Litigation Moving Forward in Kansas


Lawsuits brought by businesses affected by declining U.S. corn market prices due in part to Chinese rejection of Syngenta's Agrisure Viptera have been consolidated under MDL No. 2591 and will be heard by Judge John W. Lungstrum in the District of Kansas. Read more »

TorHoerman Law is Giving Away 250 Turkeys this Thanksgiving


THL is giving away 250 turkeys to local needy families on November 18th at 10 am at the Salvation Army of Alton.  Email for more information. Read more »

THL Announces Settlement of Pradaxa Litigation


TorHoerman Law is pleased to announce that the Pradaxa litigation that it has helped lead since before the Multi-District Litigation (MDL) was formed is set to be resolved by settlement. Boehringer Ingelheim, which manufactures the drug, and lead plaintiffs’ counsel, including Tor Hoerman, reached an agreement yesterday that will… Read more »

Benicar Does Not Cause Celiac Disease - Lawsuits Filed Claim Individuals Have a Sprue-Like Enteropathy


It is important to understand that Celiac disease is an autoimmune disease and has not been linked to any drug – the lawsuits being filed do not claim that individuals taking Benicar have Celiac disease. Instead, the lawsuits that are currently being filed on behalf of individuals severely injured while taking Benicar claim that Benicar caused… Read more »

HeartBleed Help from an Amateur


Okay, I’ll admit it, I have been known to use “password” on a few sites – on occasion a site requires me to add numbers or even capitalize which results a capitalized “P” and an occasional number at the end. Tricky, huh? So, given the immense amount of news in the past 24 hours that was clearly designed to keep… Read more »

Marseilles IL Flooding Update


Months after historic floods hit Marseilles, IL, the word that strikes us about this community is resilience. There is no other way to describe a community that works so hard to help neighbors dig out from damages suffered during the floods so they can go back to the life they knew as proud community members of Marseilles, a small town with a prime… Read more »

Federal Law Does Not Prevent Plaintiff's Failure to Warn Claims in Chicago Actos Litigation


This morning in preparation of the first Actos trial in Cook County, Judge Deborah Dooling heard oral arguments from both parties on Takeda Pharmaceutical's Motion for Partial Summary Judgment based upon federal preemption. Ken Brennan of TorHoerman Law argued for the Plaintiffs and cited numerous cases and regulations for the conclusion that federal… Read more »

First Actos MultiDistrict Litigation Case Begins Today


Today begins the first Actos MDL case in the US District Court, Western District of Louisiana. Jury was selected on Friday and today begins opening statements in the case of Terrence Allen, a man who was diagnosed with bladder cancer in January 2011 after taking Actos pursuant to a prescription starting in June 2006. Mr. Allen’s lawsuit claims… Read more »

Seventh Circuit Court of Appeals Calls Boehringer Ingelheim Order "Weak Kneed"


In a dissent that reads like an angry mother grounding a child for complaining about punishments provided by dad, Judge Hamilton tells Boehringer Ingelheim (hereinafter Boehringer) that the petitioner-defendant’s use of a procedure referred to as a “writ of mandamus” was weak-kneed. A “writ of mandamus” is an extraordinary… Read more »

Actos Cases Move Ahead Rules MDL Judge


On January 7, 2014, Judge Doherty, the Louisiana federal judge assigned to the multidistrict litigation (MDL) In Re:Actos, denied a Motion for Partial Summary Judgment filed by Takeda Pharmaceuticals. In ruling for the plaintiffs, Judge Doherty found that the plaintiffs did in fact satisfy their burden to show that the facts and circumstances of this case warrants the Actos cases to move forward towards a day in court. Read more »

Drug used to Treat Lennox-Gastaut Syndrome Linked to Severe Skin Reactions


FDA warns that anti-seizure drug Onfi can cause rare but serious skin reactions that can result in permanent harm and death. Read more »

Research Mounts Between Increased Risk of Pancreatic Cancer and the Type 2 Diabetes Drug Class Known as Incretin Mimetics


Scientific journals, studies and advocacy groups join the FDA in questioning the safety of the Type 2 diabetes drug class referred to as incretin mimetics, which includes brand name drugs such as Byetta, Bydureon, Victoza, Januvia and Janumet. Read more »

Despite One Loss, Juries and Regulatory Agencies Continue To Quetion Safety of Actos


Three Actos trials have made their way through courtrooms with two juries finding Takeda guilty of a negligence to warn and one jury finding for Takeda.  Large litigations such as the Actos litigation will see some losses with different factual situations.  The jury loss yesterday does not change the fact that Actos increases the risk of bladder cancer.  The FDA and a few independent agencies have stated as much and, while Actos is currently on the market in the U.S., several countries have taken it off the market. Read more »

Pancreatic Cancer from Diabetes Drugs Litigation Moves Forward


As lawsuits move forward, individuals diagnosed with pancreatitis or pancreatic cancer after taking type 2 diabetes medications are advised to determine their legal rights - fill out this survey for a quick, no cost/obligation legal consultation.   Read more »

THL is "Tank Full" for the Main Street Community Center


TorHoerman Law is proud to sponsor the Main Street Community Center (MSCC) Tank Full Trivia event. All proceeds for this event benefit a door-to-door transportation program for seniors and the disabled in the community.  Read more »


1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20   Next »

No-Obligation Free Consultation

Contact us by phone at 1-888-50-TORLAW or email us below.


Your information will be used only so that we may contact you to evaluate your case. Your contact information will never be shared or sold to anyone other than TorHoerman Law.